Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with proprietary platform developed at its laboratory facility in France. Through its wholly owned subsidiary TFChem S.A.R.L., the Company specializes in stabilizing carbohydrate molecules. The principal activities of the Company include development of cosmetic and pharmaceutical active ingredients. TFChem develops and markets its GlycoMim technology for pharmaceutical and biotechnology comp anies. TFChem’s proprietary chemistry technology can be applied to the development of several pharmaceutical domains such as cancer, diabetes, pain and inflammation and cardio-vascular diseases. Its cosmetic therapeutic area includes skincare-dark spot corrector (Rx & OTC), cell preservation and repair (including keloid and scar therapy), skincare-anti aging/anti-wrinkle and skincare-cellulite treatment. It has developed an active ingredient, TFC-1067 for the treatment of Dyschromia (Dark spots on the skin).


TSXV:SBM - Post by User

Bullboard Posts
Post by VancouverPigon Mar 27, 2017 8:56am
160 Views
Post# 26034635

The syndrome- RU in denial?

The syndrome- RU in denial?

There are no clinical studies done on this as most investors are too embarrased to speak about it ....
 

Stockholders syndrome is manifested when investors get caught up in the hype of a company and encourage friends, family and co-workers to expose their money to the hostage takers by investing in that company.

 

Stockholders syndrome has three central characteristics:

 

The investors have negative feelings about bashers or other signs that show negativity towards the company that holds their money hostage.

The investors have positive feelings toward the company holding their money hostage.

The investors develop entrenched positive feelings toward the actions of the company holding their money hostage.

 

Stockholders syndrome does not affect all investors (or investors in comparable situations); in fact many investors do not develop Stockholders syndrome and may become bashers. It has been concluded that three factors are necessary for stockholders syndrome to develop:

 

The investment time and their money is held hostage longer than expected.

The hostage takers of the investors money remain in contact with the investors; that is, the investors are given the sense of being in the loop as if they are all sitting in the same room with their investment

The hostage takers show some kindness toward the investors or at least refrain from harming them by not giving out bad news and only assurances that their money is safe. Investors that keep a distance and do not engage the hostage takers directly are more apt to feel anger toward the hostage takers and do not usually develop the syndrome.

 

In addition, people who often feel helpless in consoling  friends, relatives and co-workers are willing to do anything in order to support their investment strategy and decisions and  seem to be more susceptible to developing Stockholder syndrome if their money has been taken hostage.

Signed: VancouverPig..who has not got Stockholders Syndrome 



Bullboard Posts